Universal Vision (Taiwan) Insiders
| 3218 Stock | TWD 207.00 9.00 4.17% |
Universal Vision employs about 21 people. The company is managed by 6 executives with a total tenure of roughly 49 years, averaging almost 8.0 years of service per executive, having 3.5 employees per reported executive. Recap of Universal Vision's management performance can provide insight into the venture performance.
| Yuchi Chan Insider Director Division |
| Kenneth Lu Insider President |
Universal |
Universal Vision Management Team Effectiveness
The company has return on total asset (ROA) of 0.1633 % which means that it generated a profit of $0.1633 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3407 %, meaning that it generated $0.3407 on every $100 dollars invested by stockholders. Universal Vision's management efficiency ratios could be used to measure how well Universal Vision manages its routine affairs as well as how well it operates its assets and liabilities.Universal Vision Workforce Comparison
Universal Vision Biotechnology is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 3,198. Universal Vision maintains roughly 21.0 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of 0.24 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.31 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.31. Universal Vision Bio Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Universal Vision Bio Price Series Summation is a cross summation of Universal Vision price series and its benchmark/peer.
Universal Vision Notable Stakeholders
An Universal Vision stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Universal Vision often face trade-offs trying to please all of them. Universal Vision's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Universal Vision's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Yuchi Chan | Director Division | Profile | |
| Kenneth Lu | President | Profile | |
| Cindy Sun | Principal Officer | Profile | |
| ChienHsiang Yu | Director Division | Profile | |
| PiJung Lin | CTO Founder | Profile | |
| ShuHsin Lin | Chief Office | Profile |
About Universal Vision Management Performance
The success or failure of an entity such as Universal Vision Bio often depends on how effective the management is. Universal Vision management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Universal management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Universal management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan. UNIVERSAL VISION is traded on Taiwan OTC Exchange in Taiwan.
Please note, the imprecision that can be found in Universal Vision's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Universal Vision Biotechnology. Check Universal Vision's Beneish M Score to see the likelihood of Universal Vision's management manipulating its earnings.
Universal Vision Workforce Analysis
Traditionally, organizations such as Universal Vision use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Universal Vision within its industry.Universal Vision Manpower Efficiency
Return on Universal Vision Manpower
| Revenue Per Employee | 125.3M | |
| Revenue Per Executive | 438.6M | |
| Net Income Per Employee | 28.4M | |
| Net Income Per Executive | 99.2M |
Additional Tools for Universal Stock Analysis
When running Universal Vision's price analysis, check to measure Universal Vision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Vision is operating at the current time. Most of Universal Vision's value examination focuses on studying past and present price action to predict the probability of Universal Vision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Vision's price. Additionally, you may evaluate how the addition of Universal Vision to your portfolios can decrease your overall portfolio volatility.